10x Genomics Inc. (TXG) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for 10x Genomics Inc. (TXG:NASDAQ), powered by AI.

Current Price
$20.21
P/E Ratio
-64.2
Market Cap
2.8B
Sector
Healthcare
What is the 10x Genomics Inc. stock price forecast?

10x Genomics Inc. is currently trading at $20.21. View real-time AI analysis on Alpha Lenz.

What is 10x Genomics Inc. insider trading activity?

View the latest insider trading data for 10x Genomics Inc. on Alpha Lenz.

What is 10x Genomics Inc.'s P/E ratio?

10x Genomics Inc.'s P/E ratio is -64.2.

10x Genomics Inc.

NASDAQ · TXG
$20.21-2.21(-9.86%)LiveNASDAQ regular session 09:30–16:00 ET
Ask about 10x Genomics Inc.'s future dividend policy...
Alpha Chat Insight

10x Genomics Inc. trades at a P/E of -64.2 (undervalued) with modest ROE of -5.8%.

Ask for details

Company Overview

10x Genomics Inc. is a biotechnology company known for developing advanced genomic analysis technologies designed to power breakthroughs in biological research. The primary purpose of 10x Genomics is to enhance the understanding of complex biological systems by providing tools that offer insights into cellular and molecular structures at unprecedented resolutions. The company's products include innovative single-cell and spatial gene expression platforms, which are instrumental in studying genetic variations, gene expression, and complex biological phenomena across numerous sectors. Notable for its impact on life sciences and healthcare industries, 10x Genomics serves researchers in fields such as oncology, immunology, and neuroscience, among others, enabling them to explore genetic foundations of health and disease more deeply. Headquartered in Pleasanton, California, 10x Genomics plays a significant role in facilitating scientific advancements and accelerates discovery in translational and clinical research settings, contributing to the broader pursuit of personalized medicine and novel therapeutic strategies.

CEODr. Serge Saxonov Ph.D.
SectorHealthcare
IndustryHealth Information Services
Employees1,306

Company Statistics

FY 2025

Profile

$2.80BMarket Cap
$642.82MRevenue
0.00Shares Out
1,306Employees

Margins

69.05%Gross
-7.15%EBITDA
-17.25%Operating
-6.21%Pre-Tax
-6.77%Net

Valuation

-64.23P/E
3.51P/B
4.35EV/Sales
-52.34EV/EBITDA
21.50P/FCF

Growth (CAGR)

7.57%Rev 3Yr
16.55%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-4.44%ROA
-5.78%ROE
-4.07%ROIC

Financial Health

$473.97MCash & Cash Equivalents
$-228.93MNet Debt
30.77%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

10x Genomics Inc. (ticker: TXG) is a company listed on NASDAQ in the Healthcare sector (Health Information Services). It has approximately 1,306 employees. Market cap is $2.8B.

The current price is $20.21 with a P/E ratio of -64.23x and P/B of 3.51x.

ROE is -5.78% and operating margin is -17.25%. Annual revenue is $643M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
10x Genomics Inc. (Healthcare) Stock Forecast & Analysis $20.21 | Alpha Lenz